Vetter Pharma International GmbH


Vetter Pharma International GmbH

Established: ​1950

Number of staff: ​Approximately 4,900

Key Personnel: ​Thomas Otto, managing director; Peter Soelkner, managing director


Who we are:

Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. The company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to social responsibility including environmental protection and sustainability. 

Major Markets:​ Europe, North America & Asia


Services Offered:

Vetter Development Service ​includes:

–Formulation support

–Process development

–Clinical trial manufacturing

–Analytical service

–Regulatory support


Vetter Commercial Manufacturing ​includes:

–Fill and finish

–Analytical service

–Regulatory support

–Product life cycle management


Vetter Packaging Solutions ​include:

–Customized packaging development

–Specialized technologies

–Proven platform technologies

–Packaging services


Dosage forms:​ Syringes, cartridges and vials

Related resources

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Vetter Pharma

Meeting the challenges of complex drug substances

Vetter Pharma International GmbH | 15-Apr-2014 | Technical / White Paper

Realizing the full potential of an injectable drug compound is no small task. In the months and years that lead from the discovery phase to the rigorous...

Vetter – Answers that work

Vetter – Answers that work

Vetter Pharma International GmbH | 03-Oct-2012 | Data Sheet

There are many sides to your product’s success. Build them together at Vetter.Whether your injectable is still at the starting line or in full-scale production, there...